$6.220
+0.123 (+1.97%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
EBS 相似圖表分析預測
Alphio's EBS stock price prediction model matches the current Emergent BioSolutions Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.41 (-0.80%). The 1-week path is $6.45 (-0.13%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Emergent BioSolutions Inc 股票嗎？
Emergent BioSolutions Inc (EBS) is not a good buy right now due to a significant net loss of $180.2 million reported in Q2 2026, alongside a current price of $5.91 that is well below its 200-day moving average of $9.14. Additionally, the RSI is at 72.702, indicating the stock is overbought, and insider selling has increased by 140.86%, suggesting a lack of confidence from those within the company. The main risk is the company's ongoing transition phase and competition in the naloxone market, which has led to lowered earnings expectations and price target cuts from analysts.
EBS 股價於 Tuesday 收在 $6.22，此前上漲 +1.97%
Emergent BioSolutions Inc (EBS) last closed at $6.46, gaining +3.86%. These facts feed the 1-day and 1-week EBS price prediction above.
分析師一致預期
Emergent BioSolutions Inc（EBS）：買進 5、持有 1、賣出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
Emergent BioSolutions Inc（EBS）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
相似圖表形態
近期走勢與 EBS 最接近的股票，依相似度排序。
EBS 季節性分析
Historically the probability of a positive September return for EBS is 46.51%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
EBS 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Sep 2026 | $5.05 | $6.25 | $6.27 | -3.18% |
| Oct 2026 | $6.63 | $7.63 | $9.10 | +18.14% |
| Nov 2026 | $4.09 | $6.02 | $8.10 | -6.85% |
| Dec 2026 | $4.14 | $6.42 | $7.49 | -0.58% |
2026 年，Emergent BioSolutions Inc（EBS）預計區間為 $4.09 至 $9.10。
Emergent BioSolutions Inc 2026 年月度預測
2026 年 Sep，Emergent BioSolutions Inc 預計均價 $6.25，最低 $5.05，最高 $6.27。
2026 年 Oct，Emergent BioSolutions Inc 預計均價 $7.63，最低 $6.63，最高 $9.10。
2026 年 Nov，Emergent BioSolutions Inc 預計均價 $6.02，最低 $4.09，最高 $8.10。
2026 年 Dec，Emergent BioSolutions Inc 預計均價 $6.42，最低 $4.14，最高 $7.49。
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。